Abstract
The application of NMR screening in drug discovery has recently attained heightened importance throughout the pharmaceutical industry. NMR screening can be applied at various points in a drug discovery program, ranging from very early in the program, when new targets can be screened long before an HTS enzymatic assay is developed, to later in the program, as in the case where no useful hits have been detected by HTS using biological assays. The binders determined in primary NMR screens are used to guide secondary screens, which can be either completely NMR driven or use NMR in combination with other biophysical techniques. In this review we briefly discuss the methods and techniques used in NMR screening. Then, we describe in detail the NMR screening strategies and their applications to specific targets, including successful examples from actual drug design programs at our own and other pharmaceutical companies.
Keywords: NMR Screening, HTS enzymatic assay
Current Topics in Medicinal Chemistry
Title: Application of NMR Screening in Drug Discovery
Volume: 3 Issue: 1
Author(s): Jasna Fejzo, Christopher Lepre and Xiaoling Xie
Affiliation:
Keywords: NMR Screening, HTS enzymatic assay
Abstract: The application of NMR screening in drug discovery has recently attained heightened importance throughout the pharmaceutical industry. NMR screening can be applied at various points in a drug discovery program, ranging from very early in the program, when new targets can be screened long before an HTS enzymatic assay is developed, to later in the program, as in the case where no useful hits have been detected by HTS using biological assays. The binders determined in primary NMR screens are used to guide secondary screens, which can be either completely NMR driven or use NMR in combination with other biophysical techniques. In this review we briefly discuss the methods and techniques used in NMR screening. Then, we describe in detail the NMR screening strategies and their applications to specific targets, including successful examples from actual drug design programs at our own and other pharmaceutical companies.
Export Options
About this article
Cite this article as:
Fejzo Jasna, Lepre Christopher and Xie Xiaoling, Application of NMR Screening in Drug Discovery, Current Topics in Medicinal Chemistry 2003; 3 (1) . https://dx.doi.org/10.2174/1568026033392796
| DOI https://dx.doi.org/10.2174/1568026033392796 |
Print ISSN 1568-0266 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Artificial intelligence and In Silico Strategies for Novel Target Identification in Alzheimer's Disease
The title "Artificial Intelligence and In Silico Strategies for Novel Target Identification in Alzheimer's Disease" emphasizes the use of Artificial intelligence (AI) and advanced in silico methods to address Alzheimer's disease (AD), a neurodegenerative condition that currently has few effective treatments. AI and insilico methods, including molecular modeling, simulations, are ...read more
Big Data in Biomedicine: Integrating Bioinformatics and Clinical Databases
The rapid advancement of big data technologies is transforming biomedicine by integrating bioinformatics and clinical databases to drive precision medicine and innovative healthcare solutions. This thematic issue explores the intersection of computational biology, machine learning, and biomedical informatics, highlighting how large-scale data analysis enhances disease diagnosis, biomarker discovery, and personalized ...read more
Enzyme-Targeted Drug Discovery: Emerging Targets, Strategic Approaches, and Evaluation Frameworks
Enzyme-targeted drug discovery represents one of the most relevant strategies in pharmaceutical development, owing to the high specificity, selectivity, and central role of enzymes in the regulation of biological processes. This proposed issue aims to compile key information on the current landscape of enzyme-targeted drug discovery, with emphasis on the ...read more
From Code to Cure: The Evolving Landscape of Computer-Aided Drug Discovery and AI-Driven Design
Advancements in computational science and high-performance computing have made computer-aided drug design (CADD) a fundamental approach in modern drug discovery. CADD enables precise molecular-level analysis of target binding sites and interaction mechanisms, expediting the identification and refinement of drug candidates. It comprises structure-based drug design (SBDD), enhanced by crystallography and ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Microemulsions as Carriers for Therapeutic Molecules
Recent Patents on Drug Delivery & Formulation Low-Dose Mercury Exposure in Early Life: Relevance of Thimerosal to Fetuses, Newborns and Infants
Current Medicinal Chemistry The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview
Current Pharmaceutical Design Synthesis and Evaluation of the Anticonvulsant Activities of New 5-substitued-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one Derivatives
Letters in Drug Design & Discovery Caffeine: Cognitive and Physical Performance Enhancer or Psychoactive Drug?
Current Neuropharmacology Anesthetics as Chemical Tools to Study the Structure and Function of Nicotinic Acetylcholine Receptors
Current Protein & Peptide Science Editorial (Thematic Issue: The Activity of Products From Cnidaria: A Therapeutic Tool in Neurological Diseases? Part II)
Central Nervous System Agents in Medicinal Chemistry Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Preface
Current Pharmaceutical Design 3D Printing in Pharmaceuticals: Regulatory Perspective
Current Pharmaceutical Design The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H<sub>3</sub> Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary Investigation
Current Alzheimer Research Status of Selinum spp. L. a Himalayan Medicinal Plant in India: A Review of Its Pharmacology, Phytochemistry and Traditional Uses
Current Pharmaceutical Biotechnology Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective
Current Gene Therapy Preface
Current Drug Targets - CNS & Neurological Disorders Sodium Valproate Induced Tremor in a Patient with Epilepsy and Down's Syndrome
Current Drug Safety Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Opportunities and Challenges in Nano-structure Mediated Drug Delivery: Where Do We Stand?
Current Nanomedicine Editorial
Current Medical Imaging The Role of Blood-Brain Barrier Transporters in Pathophysiology and Pharmacotherapy of Stroke
Current Pharmaceutical Design Relevance of CYP2C9 Function in Valproate Therapy
Current Neuropharmacology





